Clinical trials recruiting for Multiple Sclerosis (MS) - Relapsing-remitting

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• "Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
  NCT07222618 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
  NCT07758270 · Phase: Not specified · Ages: 40 Years to 70 Years · Sex: All (male and female) · 1 location
• Combined Motor Imagery and Vestibular Rehab for MS
  NCT07230015 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Deuterium Metabolic Imaging in People with Multiple Sclerosis
  NCT06611280 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Effects of Ublituximab on Motor Functions in Multiple Sclerosis
  NCT06629428 · Phase: Early Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
  NCT06864936 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Home Based Functional Balance Intervention for Multiple Sclerosis
  NCT07355387 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 90 Years · Sex: All (male and female) · 1 location
• Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity
  NCT07292480 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
  NCT07360977 · Phase: Not applicable (e.g. observational or device study) · Ages: 1 Year to 75 Years · Sex: All (male and female) · 1 location
• Sexual Dysfunction in Women With Multiple Sclerosis (MS)
  NCT07193823 · Phase: Not specified · Ages: 25 Years to 50 Years · Sex: Female · 1 location
• Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
  NCT07225361 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
  NCT07376772 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Multiple Sclerosis (MS) - Relapsing-remitting often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Multiple Sclerosis (MS) - Relapsing-remitting trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.